# A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

> **NCT06010342** · PHASE2 · RECRUITING · sponsor: **Teligene US** · enrollment: 60 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** TL118 Capsule

## Key facts

- **NCT ID:** NCT06010342
- **Lead sponsor:** Teligene US
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-16
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06010342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06010342, "A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06010342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*